{"nct_id":"NCT06185543","title":"A Phase 2, Randomized, Prospective Double-Blind, Single-Center, Placebo-controlled Study to Evaluate Safety, Tolerability, Target Engagement, and Efficacy of PrimeC in Patients With Mild to Moderate Alzheimer's Disease.","status":"RECRUITING","status_verified_date":"2024-01","start_date":"2023-11-19","start_date_type":"ACTUAL","primary_completion_date":"2025-11","primary_completion_date_type":"ESTIMATED","completion_date":"2025-11","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["NRSN"]}